Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,320

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,320 results for “degenerate”

Learn how ShareScore rates datasets ↗
zenodo28/100

Supplementary material 3 from: Weigand AM, Macher J-N (2018) A DNA metabarcoding protocol for hyporheic freshwater meiofauna: Evaluating highly degenerate COI primers and replication strategy. Metabarcoding and Metagenomics 2: e26869. https://doi.org/10.3897/mbmg.2.26869

Figure S2: Taxonomic composition of hyporheic community with all metazoan MOTUs :

opencc-zeroAug 2018View details →
zenodo28/100

Supplementary material 5 from: Weigand AM, Macher J-N (2018) A DNA metabarcoding protocol for hyporheic freshwater meiofauna: Evaluating highly degenerate COI primers and replication strategy. Metabarcoding and Metagenomics 2: e26869. https://doi.org/10.3897/mbmg.2.26869

Table S2: Primer combinations :

opencc-zeroAug 2018View details →
zenodo28/100

Supplementary material 2 from: Weigand AM, Macher J-N (2018) A DNA metabarcoding protocol for hyporheic freshwater meiofauna: Evaluating highly degenerate COI primers and replication strategy. Metabarcoding and Metagenomics 2: e26869. https://doi.org/10.3897/mbmg.2.26869

Figure S1: Overview of sediment characteristics :

opencc-zeroAug 2018View details →
zenodo28/100

Supplementary material 4 from: Weigand AM, Macher J-N (2018) A DNA metabarcoding protocol for hyporheic freshwater meiofauna: Evaluating highly degenerate COI primers and replication strategy. Metabarcoding and Metagenomics 2: e26869. https://doi.org/10.3897/mbmg.2.26869

Table S1: Sampling site coordinates :

opencc-zeroAug 2018View details →
zenodo28/100

Supplementary material 1 from: Weigand AM, Macher J-N (2018) A DNA metabarcoding protocol for hyporheic freshwater meiofauna: Evaluating highly degenerate COI primers and replication strategy. Metabarcoding and Metagenomics 2: e26869. https://doi.org/10.3897/mbmg.2.26869

DNA extraction protocol :

opencc-zeroAug 2018View details →
zenodo28/100

Histological validation of per-bundle water diffusion metrics within a region of fiber crossing following axonal degeneration - Synthetic data

<p>Analysis of dMRI of the optic chiasm using CSD revealed unexpectedly high AFD of the intact bundle in the experimental animals. To evaluate whether this finding is an artifact produced by CSD, we used analytic synthetic data. Using the multi-tensor model, two sets of synthetic dMRI data were created consisting of 100 voxels, each with two tensors crossing at right angles. For each voxel, one tensor was modelled as an &ldquo;intact&rdquo; fiber bundle, following the DTI metrics observed in our experimental data (&lambda;∥=0.64 and &lambda;⟂=0.12 &times;10-3 mm&sup2;/s), while the other tensor was modelled as an &ldquo;injured&rdquo; fiber bundle (&lambda;∥=0.42 and &lambda;⟂=0.22 &times;10-3 mm&sup2;/s). &nbsp;Volume fractions were set as f=0.5 for both tensors. The multi-shell scheme to generate the synthetic signals consisted of 20 b=0 s/mm&sup2;, and 160 DWI volumes, consisting of 80 diffusion gradient orientations, each with two distinct b values, namely b=1000 and 3000 s/mm&sup2;. Signal-to-noise ratio was set at 20.&nbsp;</p> <p>Diffusion-weighted parameters are shown in the corresponding *protocol.txt files, organized as in the MRtrix gradient scheme (https://mrtrix.readthedocs.io/en/latest/concepts/dw_scheme.html), namely one row per volume, each containing the vector [x y z b], where x, y, and z, correspond to the components of the diffusion gradient direction, and b is the b value in s/mm^2.</p> <p>Refers to:</p> <p>Rojas-Vite, Gilberto, Coronado-Leija, Ricardo, Narvaez-Delgado, Omar, Ramirez-Manzanares, Alonso, Marroquin, Jose-Luis, Noguez-Imm, Ramses, Aranda, Marcos L, Scherrer, Benoit, Larriva-Sahd, Jorge, Concha, Luis: Histological validation of per-bundle water diffusion metrics within a region of fiber crossing following axonal degeneration , Available at&nbsp; bioRxiv, doi.org/10.1101/571539, 2019.</p>

opencc-by-4.0Jun 2019View details →
zenodo28/100

Observation of Pauli blocking in light scattering from quantum degenerate fermions

<p>The experimental data and code required to calculate the modelling results.&nbsp;</p>

opencc-by-4.0Sep 2021View details →
dryad28/100

Supplementary material for: Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease

<p><span><span><span><span><span><span><span><span><span><span><span><b>Objective:</b> <span><span>To<b> </b>test the hypothesis that<b> </b>plasma total tau (t-tau) and neurofilament light chain (NfL) concentrations may have a differential role in the study of frontotemporal lobar degeneration syndromes (FTLD-S) and clinically-diagnosed Alzheimer's disease (AD-S), we determined their diagnostic and prognostic value in FTLD-S and AD-S and their sensitivity to pathological diagnoses.</span></span></span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Methods:</b> We measured plasma t-tau and NfL with the Simoa platform in 265 participants: 167 FTLD-S, 43 AD-S, and 55 healthy controls (HC), including 82 pathology-proven cases (50 FTLD-Tau, 18 FTLD-TDP, 2 FTLD-FUS, and 12 AD) and 98 participants with amyloid PET. We compared cross-sectional and longitudinal biomarker concentrations between groups, their correlation with clinical measures of disease severity, progression and survival and cortical thickness.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Results:</b> Plasma NfL, but not plasma t-tau discriminated FTLD-S from HC and AD-S from HC. Both plasma NfL and t-tau were poor discriminators between FLTD-S and AD-S. In pathology confirmed cases, plasma NfL was higher in FTLD than AD and in FTLD-TDP compared to FTLD-Tau, after accounting for age and disease severity. Plasma NfL, but not plasma t-tau, predicted clinical decline and survival and correlated with regional cortical thickness in both FTLD-S and AD-S. The combination of plasma NfL with plasma t-tau did not outperform plasma NfL alone.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Conclusions:</b> Plasma NfL is superior to plasma t-tau for the diagnosis and prediction of clinical progression of FTLD-S and AD-S.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><b>Classification of Evidence:</b> This study provides Class III evidence that plasma NfL has superior diagnostic and prognostic performance than plasma t-tau in FTLD and AD. </span></span></span></span></span></span></span></span></span></span></span></p>

opencc-zeroOct 2021View details →
zenodo28/100

Dataset of Clinical Trial Protocols for Intervertebral Disc Degeneration Management (2013-2024)

<div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <p>This dataset encompasses a detailed collection of clinical trial protocols focused on the management of Intervertebral Disc Degeneration (IVD) from January 2013 to September 2024. It includes a diverse range of interventions, highlighting device, drug, and biological treatments, and documents the evolving strategies in response to the shifting landscape of pain management, particularly in the post-opioid epidemic era. The protocols have been rigorously compiled to identify trends, assess the effectiveness of various treatment modalities, and pinpoint knowledge gaps in the current research. By providing standardized data, this dataset serves as a valuable resource for researchers and clinicians aiming to enhance therapeutic approaches and outcomes for IVD patients worldwide. The inclusion of multiple intervention types and the comprehensive nature of the data make this collection a pivotal tool for advancing research and improving patient care in the field of spinal health.</p> </div> </div> </div> </div> </div> <div> <div>&nbsp;</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div> <div> <div> <div> <div> <div>&nbsp;</div> <div> <div> <div> <div> <div> <div>&nbsp;</div> </div> </div> <div>&nbsp;</div> </div> </div> </div> </div> </div> </div> </div> </div>

opencc-by-4.0Sep 2024View details →
ClinicalTrials.gov28/100

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

ClinicalTrials.gov study NCT03313401. IPD Sharing: NO. Countries: 0. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)

ClinicalTrials.gov study NCT03861234. IPD Sharing: NO. Countries: 3. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration

ClinicalTrials.gov study NCT04895293. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

ClinicalTrials.gov study NCT01134055. IPD Sharing: Not stated. Countries: 9. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Lucentis in Advanced Macular Degeneration

ClinicalTrials.gov study NCT00896779. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

ClinicalTrials.gov study NCT05275205. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

ClinicalTrials.gov study NCT01722045. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

ClinicalTrials.gov study NCT00460408. IPD Sharing: Not stated. Countries: 13. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

ClinicalTrials.gov study NCT00239928. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov study NCT07064759. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

ClinicalTrials.gov study NCT06864988. IPD Sharing: YES. Countries: 2. Publications: 0.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.